---
document_datetime: 2023-09-21 20:26:59
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sibnayal-epar-all-authorised-presentations_en.pdf
document_name: sibnayal-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.5350455
conversion_datetime: 2025-12-25 06:32:31.530324
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/20/1517/001   | SIBNAYAL   | 8 mEq   | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 282 mg / 527 mg   | 60 sachets                       |
|--------------------|------------|---------|------------------------------|------------|--------------------------|-------------------|----------------------------------|
| EU/1/20/1517/002   | SIBNAYAL   | 8 mEq   | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 282 mg / 527 mg   | 120 (2 x 60) sachets (multipack) |
| EU/1/20/1517/003   | SIBNAYAL   | 8 mEq   | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 282 mg / 527 mg   | 180 (3 x 60) sachets (multipack) |
| EU/1/20/1517/004   | SIBNAYAL   | 8 mEq   | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 282 mg / 527 mg   | 240 (4 x 60) sachets (multipack) |
| EU/1/20/1517/005   | SIBNAYAL   | 8 mEq   | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 282 mg / 527 mg   | 300 (5 x 60) sachets (multipack) |
| EU/1/20/1517/006   | SIBNAYAL   | 8 mEq   | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 282 mg / 527 mg   | 360 (6 x 60) sachets (multipack) |
| EU/1/20/1517/007   | SIBNAYAL   | 24 mEq  | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 847 mg / 1582 mg  | 60 sachets                       |
| EU/1/20/1517/008   | SIBNAYAL   | 24 mEq  | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 847 mg / 1582 mg  | 120 (2 x 60) sachets (multipack) |
| EU/1/20/1517/009   | SIBNAYAL   | 24 mEq  | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 847 mg / 1582 mg  | 180 (3 x 60) sachets (multipack) |
| EU/1/20/1517/010   | SIBNAYAL   | 24 mEq  | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 847 mg / 1582 mg  | 240 (4 x 60) sachets (multipack) |
| EU/1/20/1517/011   | SIBNAYAL   | 24 mEq  | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 847 mg / 1582 mg  | 300 (5 x 60) sachets (multipack) |
| EU/1/20/1517/012   | SIBNAYAL   | 24 mEq  | Prolonged-release granules   | Oral use   | sachet (PETP/alu/LDPE)   | 847 mg / 1582 mg  | 360 (6 x 60) sachets (multipack) |